ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

ANI Pharmaceuticals

09/05/2025 14:32

ANI Pharmaceuticals Inc ANIP.OQ reported quarterly adjusted earnings of $1.70​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $1.21.  The mean expectation of eight analysts for the quarter was for earnings of $1.38 per share. Wall Street expected results to range from $1.23  to $1.60 per share.

Revenue rose 43.4% to $197.12 million from a year ago; analysts expected $180.68 million.

ANI Pharmaceuticals Inc's reported EPS for the quarter was 69 cents​.

The company reported quarterly net income of $15.28 million.

ANI Pharmaceuticals Inc shares had risen by 6.8% this quarter and gained 29.4% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 26.4% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy"

Wall Street's median 12-month price target for ANI Pharmaceuticals Inc is $82.00

This summary was machine generated from LSEG data May 9 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
1.38
1.70
Beat
Dec. 31 2024
1.44
1.63
Beat
Sep. 30 2024
1.09
1.34
Beat
Jun. 30 2024
0.95
1.02
Beat